10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...
21 April 2023 - Recommendations made by the PBAC in March 2023 relating to the listing of medicines on the Pharmaceutical ...
31 March 2023 - The outcome statement from the February 2023 DUSC meeting is now available. ...
24 February 2023 - Recommendations made out of session by the PBAC between its November 2022 and March 2023 meetings are ...
27 January 2023 - Recommendations made by the PBAC in December 2022 relating to the listing of drugs on the PBS ...
22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The ...
16 December 2022 - The outcomes from the November 2022 PBAC meeting are now available. ...
24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...
3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...
14 October 2022 - The recommendations made by the PBAC in September 2022 relating to the listing of medicines on ...
19 August 2022 - The recommendations from the July 2022 PBAC meeting are now available. ...
8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...
10 July 2022 - The PBAC recommended changes to the PBS eligibility criteria for both molnupiravir (Lagevrio) and nirmatrelvir and ritonavir ...
17 June 2022 - The outcomes from the May 2022 PBAC meeting are now available. ...
5 May 2022 - The apparent high recommendation rate for the March 2022 meeting does have some downsides. ...